LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

Clinical trial NCT00526305 · COMPLETED

Trial details

NCT number: NCT00526305
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2000-01-01
Primary completion: 2005-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.